Literature DB >> 32510680

Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial.

Najibah A Galadanci1, Shehu U Abdullahi2, Shehi Ali Abubakar3, Binta Wudil Jibir4, Hauwa Aminu5, Aliyu Tijjani5, Muhammad S Abba6, Musa A Tabari7, Aisha Galadanci8, Awwal Musa Borodo9, Raymond Belonwu2, Auwal S Salihu10, Mark Rodeghier11, Djamila L Ghafuri12, Brittany V Covert C Greene12, Kathleen Neville13, Adetola A Kassim14, Fenella J Kirkham15, Lori C Jordan16, Muktar H Aliyu17, Michael R DeBaun12.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32510680      PMCID： PMC8697367          DOI： 10.1002/ajh.25900

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  7 in total

1.  Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).

Authors:  Winfred C Wang; Russell E Ware; Scott T Miller; Rathi V Iyer; James F Casella; Caterina P Minniti; Sohail Rana; Courtney D Thornburg; Zora R Rogers; Ram V Kalpatthi; Julio C Barredo; R Clark Brown; Sharada A Sarnaik; Thomas H Howard; Lynn W Wynn; Abdullah Kutlar; F Daniel Armstrong; Beatrice A Files; Jonathan C Goldsmith; Myron A Waclawiw; Xiangke Huang; Bruce W Thompson
Journal:  Lancet       Date:  2011-05-14       Impact factor: 79.321

2.  Chronic blood transfusion for primary and secondary stroke prevention in Nigerian children with sickle cell disease: a 5-year appraisal.

Authors:  I A Lagunju; B J Brown; O O Sodeinde
Journal:  Pediatr Blood Cancer       Date:  2013-08-19       Impact factor: 3.167

3.  Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial).

Authors:  Najibah A Galadanci; Shehu Umar Abdullahi; Leah D Vance; Abdulkadir Musa Tabari; Shehi Ali; Raymond Belonwu; Auwal Salihu; Aisha Amal Galadanci; Binta Wudil Jibir; Halima Bello-Manga; Kathleen Neville; Fenella J Kirkham; Yu Shyr; Sharon Phillips; Brittany V Covert; Adetola A Kassim; Lori C Jordan; Muktar H Aliyu; Michael R DeBaun
Journal:  Am J Hematol       Date:  2017-06-15       Impact factor: 10.047

4.  Cerebrovascular disease in the community: results of a WHO collaborative study.

Authors:  K Aho; P Harmsen; S Hatano; J Marquardsen; V E Smirnov; T Strasser
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

5.  Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.

Authors:  R J Adams; V C McKie; L Hsu; B Files; E Vichinsky; C Pegelow; M Abboud; D Gallagher; A Kutlar; F T Nichols; D R Bonds; D Brambilla
Journal:  N Engl J Med       Date:  1998-07-02       Impact factor: 91.245

6.  American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.

Authors:  M R DeBaun; L C Jordan; A A King; J Schatz; E Vichinsky; C K Fox; R C McKinstry; P Telfer; M A Kraut; L Daraz; F J Kirkham; M H Murad
Journal:  Blood Adv       Date:  2020-04-28

7.  Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial.

Authors:  Russell E Ware; Barry R Davis; William H Schultz; R Clark Brown; Banu Aygun; Sharada Sarnaik; Isaac Odame; Beng Fuh; Alex George; William Owen; Lori Luchtman-Jones; Zora R Rogers; Lee Hilliard; Cynthia Gauger; Connie Piccone; Margaret T Lee; Janet L Kwiatkowski; Sherron Jackson; Scott T Miller; Carla Roberts; Matthew M Heeney; Theodosia A Kalfa; Stephen Nelson; Hamayun Imran; Kerri Nottage; Ofelia Alvarez; Melissa Rhodes; Alexis A Thompson; Jennifer A Rothman; Kathleen J Helton; Donna Roberts; Jamie Coleman; Melanie J Bonner; Abdullah Kutlar; Niren Patel; John Wood; Linda Piller; Peng Wei; Judy Luden; Nicole A Mortier; Susan E Stuber; Naomi L C Luban; Alan R Cohen; Sara Pressel; Robert J Adams
Journal:  Lancet       Date:  2015-12-06       Impact factor: 79.321
  7 in total
  10 in total

Review 1.  Indications for transfusion in the management of sickle cell disease.

Authors:  Hyojeong Han; Lisa Hensch; Venée N Tubman
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 2.  The Lancet Nigeria Commission: investing in health and the future of the nation.

Authors:  Ibrahim Abubakar; Sarah L Dalglish; Blake Angell; Olutobi Sanuade; Seye Abimbola; Aishatu Lawal Adamu; Ifedayo M O Adetifa; Tim Colbourn; Afolabi Olaniyi Ogunlesi; Obinna Onwujekwe; Eme T Owoaje; Iruka N Okeke; Adebowale Adeyemo; Gambo Aliyu; Muktar H Aliyu; Sani Hussaini Aliyu; Emmanuel A Ameh; Belinda Archibong; Alex Ezeh; Muktar A Gadanya; Chikwe Ihekweazu; Vivianne Ihekweazu; Zubairu Iliyasu; Aminatu Kwaku Chiroma; Diana A Mabayoje; Mohammed Nasir Sambo; Stephen Obaro; Adesola Yinka-Ogunleye; Friday Okonofua; Tolu Oni; Olu Onyimadu; Muhammad Ali Pate; Babatunde L Salako; Faisal Shuaib; Fatimah Tsiga-Ahmed; Fatima H Zanna
Journal:  Lancet       Date:  2022-03-15       Impact factor: 202.731

3.  Strategies to increase access to basic sickle cell disease care in low- and middle-income countries.

Authors:  Meghna Dua; Halima Bello-Manga; Yvonne M Carroll; Aisha Amal Galadanci; Umma Abdulsalam Ibrahim; Allison A King; Ayobami Olanrewaju; Jeremie H Estepp
Journal:  Expert Rev Hematol       Date:  2022-04-12       Impact factor: 2.819

4.  Capacity Building for Primary Stroke Prevention Teams in Children Living With Sickle Cell Anemia in Africa.

Authors:  Djamila L Ghafuri; Brittany Covert Greene; Bilya Musa; Awwal Gambo; Abdulrasheed Sani; Shehu Abdullahi; Binta J Wudil; Halima Bello-Manga; Safiya Gambo; Matin Ghafuri; Holly Cassell; Kathleen Neville; Fenella Kirkham; Adetola A Kassim; Muktar H Aliyu; Michael R DeBaun; Lori C Jordan
Journal:  Pediatr Neurol       Date:  2021-09-04       Impact factor: 3.372

5.  Evidence-based interventions implemented in low-and middle-income countries for sickle cell disease management: A systematic review of randomized controlled trials.

Authors:  Joyce Gyamfi; Temitope Ojo; Sabrina Epou; Amy Diawara; Lotanna Dike; Deborah Adenikinju; Scholastica Enechukwu; Dorice Vieira; Obiageli Nnodu; Gbenga Ogedegbe; Emmanuel Peprah
Journal:  PLoS One       Date:  2021-02-17       Impact factor: 3.240

6.  Guidelines on sickle cell disease: primary stroke prevention in children and adolescents. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines project: Associação Médica Brasileira - 2021.

Authors:  Sandra Regina Loggetto; Mônica Pinheiro de Almeida Veríssimo; Luiz Guilherme Darrigo-Junior; Ricardo Dos Santos Simões; Wanderley Marques Bernardo; Josefina Aparecida Pellegrini Braga
Journal:  Hematol Transfus Cell Ther       Date:  2021-11-16

7.  Incidence, kinetics, and risk factors for intra- and extracranial cerebral arteriopathies in a newborn sickle cell disease cohort early assessed by transcranial and cervical color Doppler ultrasound.

Authors:  Françoise Bernaudin; Cécile Arnaud; Annie Kamdem; Isabelle Hau; Fouad Madhi; Camille Jung; Ralph Epaud; Suzanne Verlhac
Journal:  Front Neurol       Date:  2022-09-14       Impact factor: 4.086

Review 8.  Knowledge gaps in reproductive and sexual health in girls and women with sickle cell disease.

Authors:  Lydia H Pecker; Deva Sharma; Alecia Nero; Michael J Paidas; Russell E Ware; Andra H James; Kim Smith-Whitley
Journal:  Br J Haematol       Date:  2021-07-07       Impact factor: 8.615

9.  The V-BRCH Project: building clinical trial research capacity for HIV and noncommunicable diseases in Nigeria.

Authors:  Muktar H Aliyu; Mahmoud U Sani; Donna J Ingles; Fatimah I Tsiga-Ahmed; Baba M Musa; Carolyn M Audet; C William Wester
Journal:  Health Res Policy Syst       Date:  2021-03-10

10.  Establishing Sickle Cell Disease Stroke Prevention Teams in Africa is Feasible: Program Evaluation Using the RE-AIM Framework.

Authors:  Djamila L Ghafuri; Shehu U Abdullahi; Abdu H Dambatta; Jamil Galadanci; Musa A Tabari; Halima Bello-Manga; Nura Idris; Hauwa Inuwa; Aliyu Tijjani; Aisha A Suleiman; Binta W Jibir; Safiya Gambo; Awwal I Gambo; Yusuf Khalifa; Lawal Haliru; Sani Abdulrasheed; Mohammed A Zakari; Brittany C Greene; Edwin Trevathan; Lori C Jordan; Muktar H Aliyu; Ana A Baumann; Michael R DeBaun
Journal:  J Pediatr Hematol Oncol       Date:  2022-01-01       Impact factor: 1.289
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.